Outsourcing Chemistry Services Made Easy
A Guide for the Pharmaceutical and Biotech Industries
| Publication Date | January 2007 |
|---|---|
| Publisher | Biopharm Knowledge |
| Product Type | Report |
| Pages | 120 |
| ISBN Number | not applicable |
| Product Code | BKP00008 |
Summary
- Understand the rationale for outsourcing
- See how outsourcing fits into the R&D continuum
- Select process development providers
- Negotiate contracts
- Manage the outsourcing process
- Understand when to outsource - and when not to
- Minimise outsourcing risk
- Rational for outsourcing
- Research and development continuum
- Selecting a process development provider
- Contract negotiation
- Managing outsourcing
- Risk management
- Outsourcing economics
- Interviews with outsourcing companies
- Interviews with outsourcers
- Outsourcing directory
Content
- 1.0 Introduction
- 1.1 Historical Perspective
- 1.2 Report Objectives and Structure
- 1.2.1 Terminology
- 1.3 Overview of Outsourcing Markets
- 2.0 Rationale for Outsourcing
- 2.1 Reducing Cost and Maximising Profit
- 2.2 Technology
- 2.3 Capacity
- 2.4 Equipment
- 2.5 Facilities and Infrastructure
- 2.6 Skilled Personnel
- 2.7 Speed
- 2.8 Flexibility
- 2.9 Reducing Risk
- 3.0 Drug Research and Development Continuum
- 3.1 Compound Libraries
- 3.2 Competitor Standards
- 3.3 Radiolabelled Compounds
- 3.4 Custom Synthesis Options
- 3.5 Research Chemicals
- 3.6 Resynthesis Compounds
- 3.7 Outsourcing Research Services
- 3.7.1 Industry Academic Collaboration
- 3.7.2 Contract Research by FTE
- 3.8 Process Development Services
- 4.0 How to Select a Process Development Provider
- 5.0 Negotiating the Contract
- 6.0 Managing Outsourcing Contracts
- 7.0 Rationale Against Outsourcing
- 7.1 Retention of Core Competencies
- 7.2 Loss of IP
- 7.3 Internal Versus External Cost
- 7.4 Missing Deadlines
- 7.5 Missing Quality Targets
- 7.6 Lock-in Contracts
- 8.0 Minimising Outsourcing Risk
- 8.1 Ways For Limiting Probability
- 8.1.1 Structured Contractor Selection
- 8.1.2 Clearly Defined Deliverables
- 8.1.3 Setting up a Solid Contract
- 8.1.4 Monitoring and Diligence
- 8.1.5 Protection of IPR
- 8.2 Ways of Limiting Severity
- 8.2.1 Establishing Clear Strategy
- 8.2.2 Contingency Planning
- 8.2.3 Insurance Provisions
- 8.1 Ways For Limiting Probability
- 9.0 Outsourcing Economics
- 9.1 Estimating the Volume of Work
- 9.2 Estimating the Outsourcing Cost
- 9.3 Getting the Right Number of Quotations
- 9.4 Critical Comparison of Quotations
- 9.5 Off Shoring Beyond the Home Base
- 9.6 How to Pay for Outsourcing Services
- 9.6.1 Fee For Service (Fixed Cost)
- 9.6.2 Full Time Equivalent (FTE)
- 9.6.3 Flexible or Shared Risk Contracts
- 9.6.4 Best Efforts (Payment per Batch)
- 9.6.5 Time and Material
- 9.6.6 Success Fee Agreements
- 9.7 Role of Consultants in Outsourcing
- 10.0 Glossary and List of Abbreviations
- 11.0 References
- 12.0 Views and Opinions of CROs
- 12.1 Derek Faries, Business Development Manager, Charnwood Molecular Ltd
- 12.2 Dr Colin Piper, Business Development Manager, Key Organics Ltd.
- 12.3 Denise Bowser, Commercial Director, Onyx Scientific
- 13.0 Views and Opinions of Existing Outsourcers
- 13.1 Dr John Milton, Senior Director, Chemistry, Solexa, Inc.
- 13.2 Dr David Ager, Competence Manager for Homogenous Catalysis, DSM Pharma Chemicals
- 14.0 CROs Categorised by Location and Services Offered
- 14.1 Table I - United Kingdom
- 14.2 Table II - USA & Canada
- 14.3 Table III - Europe
- 14.4 Table IV - India, China, Russia & Ukraine
- 15.0 CRO Directory
- 15.1 United Kingdom
- 15.2 USA & Canada
- 15.3 Europe 96
- 15.4 India, China, Russia & Ukraine
About this Product
Delivery Details
PDF:
Related Products
Recently Viewed Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















